CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
case series review of clinical and histological dataother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04991883
NCT04991883N/ACompleted
CompareCT.gov

Analysis of the Molecular Profile of the Mixofibrosarcoma of the Extremities: Diagnostic and Prognostic Impact

Istituto Ortopedico Rizzoli·observational·Posted Aug 5, 2021·Updated May 19, 2023

In Brief

An observational study evaluating case series review of clinical and histological data for Sarcoma,Soft Tissue. Completed, enrolled 167 participants across 1 site.

Detailed Summary

Single institution case series review with a histological diagnosis of mixofibrosarcoma of the extremities from 01 Jan 1993 to 01 Dec 2017. The study will exam all the clinical, radiological, histological and immunohistochemical features of this tumour in all samples and in a limited serie of cases the presence of mutation of 50 genes cancer related.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoma,Soft Tissue
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 5, 2021
Enrollment StartSep 1, 2021
Primary CompletionDec 1, 2022
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 4.9 years ago

Interventions

case series review of clinical and histological dataother

We will review all the medical records, radiological imaging, and histological data of these cases. The immunohistochemical analysis of the principal alterated genes identified in this tumor will be performed.